Metropolitan Life Insurance Company (MetLife)’s Broadridge BR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,749
Closed -$973K 321
2024
Q1
$973K Sell
4,749
-39
-0.8% -$7.87K 0.04% 337
2023
Q4
$985K Sell
4,788
-98
-2% -$18.1K 0.05% 320
2023
Q3
$875K Sell
4,886
-255
-5% -$45.2K 0.05% 329
2023
Q2
$852K Sell
5,141
-122
-2% -$18.5K 0.04% 354
2023
Q1
$771K Sell
5,263
-1,408
-21% -$201K 0.04% 374
2022
Q4
$895K Sell
6,671
-199
-3% -$28.3K 0.04% 386
2022
Q3
$991K Sell
6,870
-81
-1% -$13.1K 0.05% 358
2022
Q2
$991K Sell
6,951
-148
-2% -$21.5K 0.04% 367
2022
Q1
$1.11M Sell
7,099
-10,991
-61% -$1.69M 0.04% 383
2021
Q4
$3.31M Sell
18,090
-386
-2% -$67.8K 0.04% 336
2021
Q3
$3.08M Sell
18,476
-608
-3% -$104K 0.04% 337
2021
Q2
$3.08M Sell
19,084
-1,048
-5% -$168K 0.04% 339
2021
Q1
$3.08M Sell
20,132
-1,146
-5% -$169K 0.05% 343
2020
Q4
$3.26M Sell
21,278
-744
-3% -$108K 0.05% 311
2020
Q3
$2.91M Sell
22,022
-851
-4% -$114K 0.05% 307
2020
Q2
$2.89M Buy
22,873
+565
+3% +$65.4K 0.05% 300
2020
Q1
$2.12M Sell
22,308
-318
-1% -$36.3K 0.04% 363
2019
Q4
$2.8M Buy
22,626
+20
+0.1% +$2.44K 0.04% 371
2019
Q3
$2.81M Sell
22,606
-327
-1% -$42.1K 0.05% 344
2019
Q2
$2.93M Buy
22,933
+1,222
+6% +$147K 0.05% 338
2019
Q1
$2.25M Sell
21,711
-969
-4% -$97.2K 0.04% 425
2018
Q4
$2.18M Sell
22,680
-54
-0.2% -$5.85K 0.04% 377
2018
Q3
$3M Sell
22,734
-846
-4% -$107K 0.05% 317
2018
Q2
$2.71M Sell
23,580
-15,470
-40% -$1.75M 0.04% 361
2018
Q1
$4.28M Buy
39,050
+272
+0.7% +$27K 0.06% 241
2017
Q4
$3.51M Sell
38,778
-76,150
-66% -$6.64M 0.05% 283
2017
Q3
$9.29M Sell
114,928
-924
-0.8% -$71.2K 0.06% 293
2017
Q2
$8.75M Buy
115,852
+920
+0.8% +$66.4K 0.06% 296
2017
Q1
$7.81M Sell
114,932
-1,010
-0.9% -$68.5K 0.05% 345
2016
Q4
$7.69M Buy
115,942
+14
+0% +$910 0.06% 336
2016
Q3
$7.86M Sell
115,928
-481
-0.4% -$32.8K 0.06% 312
2016
Q2
$7.59M Buy
116,409
+3,188
+3% +$198K 0.06% 325
2016
Q1
$6.71M Buy
113,221
+3,257
+3% +$178K 0.05% 369
2015
Q4
$5.91M Buy
109,964
+935
+0.9% +$52.4K 0.05% 419
2015
Q3
$6.04M Sell
109,029
-2,279
-2% -$122K 0.04% 411
2015
Q2
$5.57M Sell
111,308
-87
-0.1% -$4.63K 0.04% 480
2015
Q1
$6.13M Buy
111,395
+4,387
+4% +$223K 0.05% 435
2014
Q4
$4.94M Buy
107,008
+1,505
+1% +$65.8K 0.03% 543
2014
Q3
$4.39M Sell
105,503
-303
-0.3% -$12.6K 0.03% 574
2014
Q2
$4.41M Buy
105,806
+1,169
+1% +$45.8K 0.03% 603
2014
Q1
$3.89M Buy
104,637
+2,101
+2% +$78.8K 0.03% 656
2013
Q4
$4.05M Buy
102,536
+487
+0.5% +$17.6K 0.03% 617
2013
Q3
$3.24M Sell
102,049
-595
-0.6% -$17.7K 0.02% 680
2013
Q2
$2.73M Buy
+102,644
New +$2.64M 0.02% 724

Other funds holding BR

Metropolitan Life Insurance Company (MetLife)'s BR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Broadridge (BR) in Q2 2024, closing a stake of 4,749 shares — an estimated $973K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BR in Q2 2013 and held it in 44 quarters. The position peaked at $9.29M in Q3 2017. 927 funds tracked by Wall St. Rank hold BR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Broadridge position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,749 Broadridge shares in Q2 2024, an estimated $973K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Broadridge in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Broadridge position peaked at $9.29M in Q3 2017.
  • 927 funds tracked by Wall St. Rank held Broadridge as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.